Ntow-Boahene, Winnie
Papandronicou, Isabelle
Miculob, Josephous
Good, Liam
Funding for this research was provided by:
Biotechnology and Biological Sciences Research Council (BB/M009513/1, BB/M009513/1)
Blueberry therapeutics Ltd. (BB/M009513/1, BB/M009513/1)
Article History
Received: 12 September 2022
Accepted: 9 February 2023
First Online: 16 February 2023
Competing interests
: All authors are currently employees of Tecrea Ltd, a biotechnology company spin out from The Royal Veterinary College which enables nanodelivery using PHMB.